Cargando…
Protein Kinase CK1α Sustains B-Cell Receptor Signaling in Mantle Cell Lymphoma
Mantle Cell Lymphoma (MCL) is still an incurable B-cell malignancy characterized by poor prognosis and frequent relapses. B Cell Receptor (BCR) signaling inhibitors, in particular of the kinases BTK and PI3Kγ/δ, have demonstrated clinically meaningful anti-proliferative effects in B cell tumors. How...
Autores principales: | Manni, Sabrina, Fregnani, Anna, Quotti Tubi, Laura, Spinello, Zaira, Carraro, Marco, Scapinello, Greta, Visentin, Andrea, Barilà, Gregorio, Pizzi, Marco, Dei Tos, Angelo Paolo, Vianello, Fabrizio, Zambello, Renato, Gurrieri, Carmela, Semenzato, Gianpietro, Trentin, Livio, Piazza, Francesco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8551451/ https://www.ncbi.nlm.nih.gov/pubmed/34722279 http://dx.doi.org/10.3389/fonc.2021.733848 |
Ejemplares similares
-
Protein Kinase CK2 represents a new target to boost Ibrutinib and Venetoclax induced cytotoxicity in mantle cell lymphoma
por: Manni, Sabrina, et al.
Publicado: (2022) -
P1279: INHIBITION OF PROTEIN KINASE CK2 AND BCL-2: A NOVEL THERAPEUTIC STRATEGY TO ANTAGONIZE MANTLE CELL LYMPHOMA CELL GROWTH
por: Manni, S., et al.
Publicado: (2022) -
Targeting Protein Kinases in Blood Cancer: Focusing on CK1α and CK2
por: Spinello, Zaira, et al.
Publicado: (2021) -
CK1α/RUNX2 Axis in the Bone Marrow Microenvironment: A Novel Therapeutic Target in Multiple Myeloma
por: Fregnani, Anna, et al.
Publicado: (2022) -
Prosurvival autophagy is regulated by protein kinase CK1 alpha in multiple myeloma
por: Carrino, Marilena, et al.
Publicado: (2019)